e-learning
resources
Vienna 2009
Monday, 14.09.2009
Clinical aspects of inflammatory airways diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis
K. Zycinska, M. Romanowska, I. Nowak, K. Wardyn, L. Brydak (Warsaw, Poland)
Source:
Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Session:
Clinical aspects of inflammatory airways diseases
Session type:
Thematic Poster Session
Number:
2165
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Zycinska, M. Romanowska, I. Nowak, K. Wardyn, L. Brydak (Warsaw, Poland). Response to subunit influenza vaccine in lung disease due to Wegener‘s granulomatosis. Eur Respir J 2009; 34: Suppl. 53, 2165
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Understanding new vaccines for SARS-CoV-2 and their regulation
Related content which might interest you:
Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Influenza vaccine-induced interstitial lung disease
Source: Eur Respir J 2013; 41: 474-477
Year: 2013
Influenza vaccine-induced ILD
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Goodpasture syndrome after H1N1 influenza pneumonia
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Immunity to pneumococcal disease
Source: Annual Congress 2013 –New understanding of pneumococcal vaccination
Year: 2013
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
The humoral immune response to influenza vaccination in lung transplant patients
Source: Eur Respir J 2001; 18: 971-976
Year: 2001
Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept